Carbon beam therapy in recurrent ovarian cancer.
Nawa
A
A
Suzuki
K
K
Kato
S
S
Fujiwara
S
S
Kajiyama
H
H
Shibata
K
K
Ino
K
K
Nakamura
S
S
Kikkawa
F
F
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D002244:Carbon / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D018269:Carcinoma, Endometrioid / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D007044:Hysterectomy; D000077146:Irinotecan; D008197:Lymph Node Excision; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000532:radiotherapy*; D009852:Omentum / Q000601:surgery; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D010052:Ovariectomy; D017239:Paclitaxel / Q000008:administration & dosage; D011882:Radiotherapy, High-Energy; D012074:Remission Induction; D016879:Salvage Therapy / Q000379:methods*; D000093542:Gemcitabine
D003841:Deoxycytidine; D002244:Carbon; D000077146:Irinotecan; D016190:Carboplatin; D017239:Paclitaxel; D002166:Camptothecin; D000093542:Gemcitabine